Faculty

Institution

Unit

Venue

Meghana Trivedi

Professor of Pharmacy Practice and Translational Research Joint Appointment Professor of Pharmacology

University of Houston

Affiliations

College of Pharmacy

Pharmacological & Pharmaceutical Sciences

Meghana Trivedi is currently serving as a College Of Pharmacy Professor of Pharmacy Practice and Translational Research Joint Appointment Professor of Pharmacology at University of Houston.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Meghana Trivedi

University of Houston

Professor of Pharmacy Practice and Translational Research Joint Appointment Professor of Pharmacology

You can click a keyword to filter the displayed items

breast cancer cancer research oncology pharmacology cancer treatment cancer biology medicine molecular biology tumor biology cancer care endocrinology breast oncology health sciences cancer cells medicinal research endocrine oncology oncogenes cancer discovery pharmacotherapy cancer management clinical research therapeutic targets molecular cancer oral endocrine therapy cancer prevention gynecologic oncology endocrine-related cancers tumor targeting endocrine disruptors breast cancer patients cancer genetics receptors surgical oncology g protein-coupled receptor tumor suppressors breast cancer survivors enzyme inhibition hormonal receptor clinical pharmacology cancer growth cohort studies endocrine resistance vascular biology clinical nutrition respiratory medicine animal physiology gene function renal function dopamine anti-cancer agents disease progression cell regulation signaling pathways endocrine research clinical evidence er-positive breast cancer clinical implications adherence barriers postmenopausal women endocrine-resistant breast cancer molecular science molecular metabolism rna biology metabolic disorders metabolic complications metabolic control metabolic health medical nutrition therapy medical nutrition metastasis dormancy er transcriptome bidirectional crosstalk estrogen receptor biological mechanisms endocrine therapy adherence prospective observational study high-throughput screening laboratory investigation drug discovery translational research biostatistics high throughput screening omics technologies systems biology precision medicine omics integration omics

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 2027: Developing an Image Analysis Algorithm to Evaluate Immunofluorescence Intensity for Rb and Phospho-Rb Expression in Circulating Tumor Cells in Hr+/Her2- Breast Cancer. Cancer Research (2025)

Shivaani Suresh KannaMantasha TabassumMeghana V. Trivedi

breast cancerimage analysis algorithmimmunofluorescence intensitycancer researchtumor cellsimage analysiscancer biologyphospho-rb expression

Abstract 4347: Preclinical Evaluation of Pharmacokinetic Interactions Among Nebivolol, Dasatinib and Devimistat in Mice. Cancer Research (2025)

Airong LiMikayla SkillmanFatima DagherAmir Mohammad GholizadehEmanuel BaltripJunghwa ParkMeghana TrivediS.-L. Chow Diana

pharmacokineticscancer researchpreclinical evaluationpharmacokinetic interactionspharmacology

Abstract 515: Repurposing Nebivolol With Dasatinib and Cpi-613: A Synergistic Strategy to Combat Triple-Negative Breast Cancer. Cancer Research (2025)

Mikayla SkillmanAirong LiFatima DagherDiana ChowMeghana Trivedi

breast oncologycancer researchmolecular biologytriple-negative breast cancerrepurposing nebivololcancer treatmentoncologybreast cancersynergistic strategy

Group-Based Trajectory Modeling to Identify Patterns and Predictors of Adherence to Oral Endocrine Therapies in Underserved Population of Greater Houston Area. Patient Preference and Adherence (2025)

Yashvi PatelHasan AlsaediZahra MajdIssra AltaieSama RahimiBilqees FatimaOnyebuchi OnonogbuSusan AbughoshMeghana Trivedi

health services researchbiostatisticspublic healthhealth careoral endocrine therapiessymptom managementgreater houston areagroup-based trajectoryoutcomes researchpatient-centered outcomesmedicinepatient satisfactionpopulation healthcase studies

Interactions Between Adgrf1 (Gpr110) and Extracellular Matrix Proteins Govern Its Effects on Tumorigenesis in Her2‐Positive Breast Cancer. British Journal of Pharmacology (2025)

Noor Mazin AbdulkareemRaksha BhatMicah CastilloSung Yun JungSuhas VasaikarSarmistha NandaAlexis RuizMartin SheaWangjia CaoJamunarani VeeraraghavanHee‐Yong KimTasneem Bawa‐KhalfeTahir HussainXinli LiuPreethi GunaratneRachel SchiffMeghana V. Trivedi

pharmacologybreast cancercancer biology

Non-Adherence of Cyclin-Dependent Kinases 4 and 6 Inhibitors Reduces Overall and Progression-Free Survival in Patients With Hormone Receptor–Positive Breast Cancer. Breast Cancer Research and Treatment (2025)

Connie LauKrista LaBordeBilqees FatimaShahad S AlfartosySusan AbughoshRodrigo De La TorreErika N BrownMeghana V Trivedi

breast oncologygynecologic oncologyepidemiologysurgical oncologydisease progressionchemoprevention strategiescancer discoverypharmacologybreast cancertumor biologycancer preventionprogression-free survivalcancer researchcancer treatmentoncogenesmedicinal researchbiostatisticsclinical researchoncology

Abstract 5166: A Multiplexed Immunofluorescence Assay to Assess Rb and Phospho-Rb as Predictive Biomarkers for Cdk4/6 Inhibitors in Hr+/Her2- Breast Cancer. Cancer Research (2024)

Mantasha TabassumShivaani Suresh KannaWangjia CaoMothaffar RimawiGeorge E MilesMeghana V Trivedi

biomarker discoveryprognostic biomarkerscancer biologymultiplexed immunofluorescence assaybiomarker targetcancer researchcancer discoverymolecular biologytherapeutic targetsbiomarkerscancer treatmentbreast cancerpredictive biomarkers

Abstract Po3-09-09: Interventions to Improve Adherence to Oral Endocrine Therapy for Prevention or Treatment of Breast Cancer in African American Women of Low Socioeconomic Status. Cancer Research (2024)

Camille JohnsonAnn AdigweNicole EkezieBilqees FatimaZahra MajdKeith HoukTejal PatelRob ShimkoOnyebuchi OnonogbuSusan AbughoshMeghana Trivedi

health promotionhealth preventionbreast cancerpreventive medicinecancer preventioncancer researchcancer treatmentoral endocrine therapyhealth policypublic healthmedicinal researchcancer disparitiescancer careoncologyafrican american womenwomen's healthtreatment and preventionmedicinelow socioeconomic status

Comparing the Effects of Various β-Blockers on Cardiovascular Mortality in Breast Cancer Patients. Cardio-Oncology (2024)

Mantasha TabassumSoumya G. ChikermaneCamille JohnsonNoor M. AbdulkareemElisabeth M. WangMichael L. JohnsonMeghana V. Trivedi

cardiovascular diseasepharmacologybreast cancercardiovascular interventionsbreast cancer patientscancer treatmentpharmacotherapypublic healthcardiologymedicinal researchthrombosisimmune checkpoint inhibitorscardiovascular researchcardiovascular mortalitycohort studiestreatment and preventionsurvival analysismedicineanticoagulantsoncology

Factors Associated With the Use of Immune Checkpoint Inhibitors in Older Adults With Metastatic Non-Small Cell Lung Cancer and Pre-Existing Autoimmune Disease: A Seer-Medicare Study. Journal of Geriatric Oncology (2024)

Shrey GohilHua ChenWhitney E LewisMeghana TrivediRajender R AparasuMichael L Johnson

pre-existing autoimmune diseaseimmunologylung cancerolder adultsimmune checkpoint inhibitorsseer-medicare study

1
2
3
4
5
10
10 / page

Meghana Trivedi

Professor of Pharmacy Practice and Translational Research Joint Appointment Professor of Pharmacology

University of Houston

Affiliations

College of Pharmacy

Pharmacological & Pharmaceutical Sciences

Meghana Trivedi is currently serving as a College Of Pharmacy Professor of Pharmacy Practice and Translational Research Joint Appointment Professor of Pharmacology at University of Houston.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Meghana Trivedi

University of Houston

Professor of Pharmacy Practice and Translational Research Joint Appointment Professor of Pharmacology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Shivaani Suresh KannaMantasha TabassumMeghana V. Trivedi

breast cancerimage analysis algorithmimmunofluorescence intensitycancer researchtumor cellsimage analysiscancer biologyphospho-rb expression

Abstract 4347: Preclinical Evaluation of Pharmacokinetic Interactions Among Nebivolol, Dasatinib and Devimistat in Mice. Cancer Research (2025)

Airong LiMikayla SkillmanFatima DagherAmir Mohammad GholizadehEmanuel BaltripJunghwa ParkMeghana TrivediS.-L. Chow Diana

pharmacokineticscancer researchpreclinical evaluationpharmacokinetic interactionspharmacology

Abstract 515: Repurposing Nebivolol With Dasatinib and Cpi-613: A Synergistic Strategy to Combat Triple-Negative Breast Cancer. Cancer Research (2025)

Mikayla SkillmanAirong LiFatima DagherDiana ChowMeghana Trivedi

breast oncologycancer researchmolecular biologytriple-negative breast cancerrepurposing nebivololcancer treatmentoncologybreast cancersynergistic strategy

Yashvi PatelHasan AlsaediZahra MajdIssra AltaieSama RahimiBilqees FatimaOnyebuchi OnonogbuSusan AbughoshMeghana Trivedi

Interactions Between Adgrf1 (Gpr110) and Extracellular Matrix Proteins Govern Its Effects on Tumorigenesis in Her2‐Positive Breast Cancer. British Journal of Pharmacology (2025)

pharmacologybreast cancercancer biology

Connie LauKrista LaBordeBilqees FatimaShahad S AlfartosySusan AbughoshRodrigo De La TorreErika N BrownMeghana V Trivedi

Abstract 5166: A Multiplexed Immunofluorescence Assay to Assess Rb and Phospho-Rb as Predictive Biomarkers for Cdk4/6 Inhibitors in Hr+/Her2- Breast Cancer. Cancer Research (2024)

Mantasha TabassumShivaani Suresh KannaWangjia CaoMothaffar RimawiGeorge E MilesMeghana V Trivedi

Camille JohnsonAnn AdigweNicole EkezieBilqees FatimaZahra MajdKeith HoukTejal PatelRob ShimkoOnyebuchi OnonogbuSusan AbughoshMeghana Trivedi

Comparing the Effects of Various β-Blockers on Cardiovascular Mortality in Breast Cancer Patients. Cardio-Oncology (2024)

Mantasha TabassumSoumya G. ChikermaneCamille JohnsonNoor M. AbdulkareemElisabeth M. WangMichael L. JohnsonMeghana V. Trivedi

Shrey GohilHua ChenWhitney E LewisMeghana TrivediRajender R AparasuMichael L Johnson

pre-existing autoimmune diseaseimmunologylung cancerolder adultsimmune checkpoint inhibitorsseer-medicare study

1
2
3
4
5
10
10 / page

Similar Faculty Members

Daniel G Stover

Institution

Ohio State University

applied artificial intelligence

multidisciplinary ai

Bhuvaneswari Ramaswamy

Institution

Ohio State University

cancer letter

cancer treatment

Robert Wesolowski

Institution

Ohio State University

oncology

cancer research

Manish Kohli

Institution

University of Utah

urology

advanced prostate cancer

Mark Pegram

Institution

Stanford University

oncology

breast cancer

Terry Hyslop

Institution

Duke University

oncology

cancer research

Elisabeth Heath

Institution

Wayne State University

translational research

prostate cancer research

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Mothaffar F. Rimawi

Institution

Baylor College of Medicine

radiation oncology

breast cancer

Kazuaki Takabe

Institution

University at Buffalo

hepatology

pathology

Similar Faculty Members

Daniel G Stover

Institution

Ohio State University

applied artificial intelligence

multidisciplinary ai

Bhuvaneswari Ramaswamy

Institution

Ohio State University

cancer letter

cancer treatment

Robert Wesolowski

Institution

Ohio State University

oncology

cancer research

Manish Kohli

Institution

University of Utah

urology

advanced prostate cancer

Mark Pegram

Institution

Stanford University

oncology

breast cancer

Terry Hyslop

Institution

Duke University

oncology

cancer research

Elisabeth Heath

Institution

Wayne State University

translational research

prostate cancer research

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Mothaffar F. Rimawi

Institution

Baylor College of Medicine

radiation oncology

breast cancer

Kazuaki Takabe

Institution

University at Buffalo

hepatology

pathology